NIH: New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed)RFA-TR-21-001
Sponsor: NIHInternal Deadline: 05/13/2021Institutional Submission Limit: 1Sponsor Deadline: 07/08/2021Program WebsiteNIH: New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed)RFA-TR-21-001
This program... seeks to facilitate translational and clinical research between NCATS intramural scientists and the extramural community to develop approaches that will enhance the ability to discover and develop new chemistries towards previously undrugged biological targets (i.e., biological targets with no known drugs to modulate their function) across many human diseases and conditions.
USC may submit only one application in response to this solicitation.
Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send an updated NIH formatted biosketch (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-073.html) and a two page abstract via email to Richard White (email@example.com) by May 13, 2021.
NIH indicates that a letter of intent IS NOT REQUIRED and a full application is due by July 8, 2021. For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-21-001.html